Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. (Record no. 24495047)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02443 a2200673 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517011236.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201504s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1527-7755 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1200/JCO.2014.57.1745 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Dang, Chau |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20150420 |
| 245 00 - TITLE STATEMENT | |
| Title | Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
| Date of publication, distribution, etc. | Feb 2015 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 442-7 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biomarkers, Tumor |
| General subdivision | analysis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Breast Neoplasms |
| General subdivision | chemistry |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Administration Schedule |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Follow-Up Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunohistochemistry |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | In Situ Hybridization, Fluorescence |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Infusions, Intravenous |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kaplan-Meier Estimate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Paclitaxel |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptor, ErbB-2 |
| General subdivision | analysis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Trastuzumab |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Iyengar, Neil |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Datko, Farrah |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | D'Andrea, Gabriella |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Theodoulou, Maria |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dickler, Maura |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Goldfarb, Shari |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lake, Diana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fasano, Julie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fornier, Monica |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gilewski, Theresa |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Modi, Shanu |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gajria, Devika |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moynahan, Mary Ellen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hamilton, Nicola |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Patil, Sujata |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jochelson, Maxine |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Norton, Larry |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Baselga, Jose |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hudis, Clifford |
| 773 0# - HOST ITEM ENTRY | |
| Title | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
| Related parts | vol. 33 |
| -- | no. 5 |
| -- | p. 442-7 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1200/JCO.2014.57.1745">https://doi.org/10.1200/JCO.2014.57.1745</a> |
| Public note | Available from publisher's website |
No items available.